Quisel John D, an insider at Disc Medicine Inc (IRON), purchased 184,128 shares of the company on December 18, 2025, at a price of $1.01 per share, amounting to a total transaction value of $186,000. Following this acquisition, Quisel now holds 184,128 shares of Disc Medicine.
Disc Medicine, a clinical-stage biopharmaceutical company based in Watertown, Massachusetts, focuses on developing treatments for hematologic diseases. The company, which went public on August 12, 2020, has a market capitalization of $3.3 billion and reported a trailing twelve-month EPS of -5.35.
The upcoming earnings report is scheduled for May 5, 2026, with an estimated EPS of -1.80 and revenue expectations of $1.4 million. Insider transactions, such as this one, provide transparency into executive sentiment but should be considered alongside other market factors.
Investors often analyze patterns of insider trading across multiple insiders and time periods for a more comprehensive view of market sentiment.